AP511A - The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). - Google Patents
The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). Download PDFInfo
- Publication number
- AP511A AP511A APAP/P/1994/000626A AP9400626A AP511A AP 511 A AP511 A AP 511A AP 9400626 A AP9400626 A AP 9400626A AP 511 A AP511 A AP 511A
- Authority
- AP
- ARIPO
- Prior art keywords
- placebo
- granisetron
- vomiting
- ponv
- nausea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Sludge (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939305593A GB9305593D0 (en) | 1993-03-18 | 1993-03-18 | Pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9400626A0 AP9400626A0 (en) | 1994-04-30 |
AP511A true AP511A (en) | 1996-07-26 |
Family
ID=10732290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1994/000626A AP511A (en) | 1993-03-18 | 1994-03-16 | The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). |
Country Status (21)
Country | Link |
---|---|
US (1) | US5952340A (ja) |
EP (1) | EP0689437B1 (ja) |
JP (2) | JP3792251B2 (ja) |
KR (1) | KR100315606B1 (ja) |
CN (1) | CN1085079C (ja) |
AP (1) | AP511A (ja) |
AT (1) | ATE230596T1 (ja) |
AU (1) | AU676032B2 (ja) |
CA (1) | CA2158354C (ja) |
CY (1) | CY2427B1 (ja) |
DE (1) | DE69431986T2 (ja) |
DK (1) | DK0689437T3 (ja) |
ES (1) | ES2188611T3 (ja) |
GB (1) | GB9305593D0 (ja) |
HK (1) | HK1012237A1 (ja) |
HU (1) | HU214629B (ja) |
IL (1) | IL109059A (ja) |
SG (1) | SG46724A1 (ja) |
TW (1) | TW312622B (ja) |
WO (1) | WO1994021257A1 (ja) |
ZA (1) | ZA941844B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
AU2003237657A1 (en) * | 2002-05-24 | 2003-12-12 | Epidauros Biotechnologie Ag | Means and methods for improved treatment using "setrones" |
SE0203410D0 (sv) * | 2002-11-18 | 2002-11-18 | Astrazeneca Ab | New use |
JO2735B1 (en) * | 2003-01-30 | 2013-09-15 | هيلسين هيلث كير أس ايه. | Liquid pharmaceutical formations of balloonosterone |
TWI355936B (en) | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
GB0328186D0 (en) * | 2003-12-05 | 2004-01-07 | West Pharm Serv Drug Res Ltd | Intranasal compositions |
JP6081102B2 (ja) * | 2012-08-10 | 2017-02-15 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤 |
GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
JP2017077484A (ja) * | 2016-11-30 | 2017-04-27 | テルモ株式会社 | 安定なグラニセトロン含有水性製剤の包装体 |
GB201702250D0 (en) | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0200444B1 (en) * | 1985-04-27 | 1992-11-11 | Beecham Group Plc | Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity |
GB8525913D0 (en) * | 1985-10-21 | 1985-11-27 | Beecham Group Plc | Compounds |
GB8928837D0 (en) * | 1989-12-21 | 1990-02-28 | Beecham Group Plc | Pharmaceuticals |
US5225407A (en) * | 1990-02-22 | 1993-07-06 | Glaxo Group Limited | 5-HT3 receptor antagonists for the treatment of autism |
DK0533280T4 (da) * | 1991-09-20 | 2005-02-28 | Glaxo Group Ltd | Ny medicinsk anvendelse af tachykininantagonister |
-
1993
- 1993-03-18 GB GB939305593A patent/GB9305593D0/en active Pending
-
1994
- 1994-03-15 DE DE69431986T patent/DE69431986T2/de not_active Revoked
- 1994-03-15 AU AU63774/94A patent/AU676032B2/en not_active Expired
- 1994-03-15 CA CA002158354A patent/CA2158354C/en not_active Expired - Lifetime
- 1994-03-15 EP EP94911178A patent/EP0689437B1/en not_active Revoked
- 1994-03-15 SG SG1996009426A patent/SG46724A1/en unknown
- 1994-03-15 KR KR1019950703945A patent/KR100315606B1/ko not_active IP Right Cessation
- 1994-03-15 HU HU9502692A patent/HU214629B/hu unknown
- 1994-03-15 JP JP52064194A patent/JP3792251B2/ja not_active Expired - Lifetime
- 1994-03-15 ES ES94911178T patent/ES2188611T3/es not_active Expired - Lifetime
- 1994-03-15 US US08/525,521 patent/US5952340A/en not_active Expired - Lifetime
- 1994-03-15 AT AT94911178T patent/ATE230596T1/de not_active IP Right Cessation
- 1994-03-15 DK DK94911178T patent/DK0689437T3/da active
- 1994-03-15 WO PCT/EP1994/000820 patent/WO1994021257A1/en active IP Right Grant
- 1994-03-16 AP APAP/P/1994/000626A patent/AP511A/en active
- 1994-03-16 ZA ZA941844A patent/ZA941844B/xx unknown
- 1994-03-21 IL IL10905994A patent/IL109059A/en not_active IP Right Cessation
- 1994-04-06 TW TW083102963A patent/TW312622B/zh not_active IP Right Cessation
- 1994-09-29 CN CN94192028A patent/CN1085079C/zh not_active Expired - Lifetime
-
1998
- 1998-12-15 HK HK98113470A patent/HK1012237A1/xx not_active IP Right Cessation
-
2004
- 2004-02-25 CY CY0400013A patent/CY2427B1/xx unknown
-
2005
- 2005-12-13 JP JP2005359022A patent/JP2006083190A/ja active Pending
Non-Patent Citations (1)
Title |
---|
NONE * |
Also Published As
Publication number | Publication date |
---|---|
US5952340A (en) | 1999-09-14 |
CY2427B1 (en) | 2004-11-12 |
JP3792251B2 (ja) | 2006-07-05 |
CN1122570A (zh) | 1996-05-15 |
JP2006083190A (ja) | 2006-03-30 |
EP0689437B1 (en) | 2003-01-08 |
ZA941844B (en) | 1995-09-18 |
HU214629B (hu) | 1998-04-28 |
HK1012237A1 (en) | 1999-07-30 |
SG46724A1 (en) | 1998-02-20 |
DE69431986D1 (de) | 2003-02-13 |
TW312622B (ja) | 1997-08-11 |
DK0689437T3 (da) | 2003-04-28 |
CA2158354A1 (en) | 1994-09-29 |
HUT73502A (en) | 1996-08-28 |
ES2188611T3 (es) | 2003-07-01 |
CA2158354C (en) | 2004-07-13 |
AU676032B2 (en) | 1997-02-27 |
JPH08507774A (ja) | 1996-08-20 |
IL109059A (en) | 1996-11-14 |
AU6377494A (en) | 1994-10-11 |
CN1085079C (zh) | 2002-05-22 |
EP0689437A1 (en) | 1996-01-03 |
ATE230596T1 (de) | 2003-01-15 |
KR100315606B1 (ko) | 2002-04-24 |
AP9400626A0 (en) | 1994-04-30 |
DE69431986T2 (de) | 2003-11-06 |
GB9305593D0 (en) | 1993-05-05 |
IL109059A0 (en) | 1994-11-28 |
HU9502692D0 (en) | 1995-11-28 |
WO1994021257A1 (en) | 1994-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940011246B1 (ko) | 로라타딘, 이부프로펜 및 슈도에페드린을 함유하는 약제학적 조성물 | |
CA1288350C (en) | Controlled release dihydrocodeine composition | |
US20040234593A1 (en) | Diphenhydramine tannate compositions and methods of use | |
DE60009697T2 (de) | Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie | |
AP511A (en) | The use of granisetron in the manufacture of a medicament for the treatment of post-operative nausea advomiting (PONV). | |
NZ504656A (en) | Substituted aminomethyl-chromans are used for the regenerative treatment of neurological conditions which are the sequelae of damage due to surgical intervention, exposure to toxic agents, infections, tumours, and other diseases and conditions | |
AU674335B2 (en) | Ophthalmological preparation | |
JPH0320222A (ja) | 脳内虚血症治療剤 | |
US20060160887A1 (en) | Medicinal composition | |
JP3150642B2 (ja) | 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法 | |
WO1998038997A1 (en) | Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia | |
JP2022533510A (ja) | グリコピロレートを含む口腔内崩壊錠剤および生物学的利用率を増大させるための方法 | |
CA2002552C (en) | Pharmaceutical aqueous solution for ophthalmic use comprising a water solube pharmaceutically acceptable acid addition salt of ibopamine | |
US4062974A (en) | Method for treating drepanocytosis | |
JPS63502270A (ja) | 散瞳作用を有する眼科用医薬組成物 | |
US6162792A (en) | Use of spiramycin for treating gastrointestinal disorders caused by H. pylori | |
AU2002236141A1 (en) | Method of treatment | |
CN1309564A (zh) | 治疗方法 | |
WO2024062443A1 (en) | Pharmaceutical compositions | |
EP0723448A1 (en) | Use of peniclorin for the treatment of posttherapeutic neuralgia | |
JP2001253825A (ja) | 帯状疱疹後神経痛用鎮痛剤 | |
MXPA01000466A (en) | Method of treatment | |
KR19980703816A (ko) | 레보부피바카인 및 임산부의 마취제로서 그것의 용도 |